Lysophosphatidic acid, ceramide 1-phosphate and sphingosine 1-phosphate in peripheral blood of patients with idiopathic pulmonary fibrosis-Reference-Cited by-同舟云学术

Lysophosphatidic acid, ceramide 1-phosphate and sphingosine 1-phosphate in peripheral blood of patients with idiopathic pulmonary fibrosis

Published:2022 Issue:3.4 Volume:69 Page:196-203
ISSN:1343-1420
Container-title:The Journal of Medical Investigation
language:en
Short-container-title:J. Med. Invest.

Author:

Tanaka Tamotsu¹,Koyama Kazuya²,Takahashi Naoko³,Morito Katsuya³,Ali Hanif⁴,Azuma Momoyo⁵,Kagawa Kozo²,Kawano Hiroshi²,Has Rumana Yesmin¹,Aihara Mutsumi¹,Nishioka Yasuhiko²

Affiliation:

1. Division of Bioscience and Bioindustry, Graduate School of Technology, Industrial and Social Sciences, Tokushima University, Tokushima, Japan

2. Department of Respiratory Medicine and Rheumatology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan

3. Department of Pharmaceutical Health Chemistry, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan

4. Department of Medical Pharmacology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan

5. Department of Infection Control and Prevention, Tokushima University Hospital, Tokushima, Japan

Publisher

University of Tokushima Faculty of Medicine

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.jstage.jst.go.jp/article/jmi/69/3.4/69_196/_pdf

Reference26 articles.

1. 1. Homma S, Bando M, Azuma A, Sakamoto S, Sugino K, Ishii Y, Izumi S, Inase N, Inoue Y, Ebina M, Ogura T, Kishi K, Kishaba T, Kido T, Gemma A, Goto Y, Sasaki S, Johkoh T, Suda T, Takahashi K, Takahashi H, Taguchi Y, Date H, Taniguchi H, Nakayama T, Nishioka Y, Hasegawa Y, Hattori N, Fukuoka J, Miyamoto A, Mukae H, Yokoyama A, Yoshino I, Watanabe K ; Ministry of Health, Labour and Welfare, the Study Group on Diffuse Pulmonary Disorders, Scientific Research / Research on Intractable Diseases, and Japanese Respiratory Society : Japanese guideline for the treatment of idiopathic pulmonary fibrosis. Respir Investig 56 : 268-291, 2018

2. 2. Wolters PJ, Collard HR, Jones KD : Pathogenesis of idiopathic pulmonary fibrosis. Annu Rev Pathol 9 : 157-79, 2014

3. 3. Saito S, Alkhatib A, Kolls JK, Kondoh Y, Lasky JA : Pharmacotherapy and adjunctive treatment for idiopathic pulmonary fibrosis (IPF). J Thorac Dis 11 : S1740-1754, 2019

4. 4. Takuwa Y, Ikeda H, Okamoto Y, Takuwa N, Yoshioka K : Sphingosine-1-phosphate as a mediator involved in development of fibrotic diseases. Biochim Biophys Acta 1831 : 185-92, 2013

5. 5. Shea BS, Tager AM : Role of lysophosphatidic acid mediators lysophosphatidic acid and sphingosine 1-phosphate in lung fibrosis. Proc Am Thorac Soc 9 : 102-110, 2012

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating metabolic profile in idiopathic pulmonary fibrosis: data from the IPF-PRO Registry;Respiratory Research;2024-01-25

2. Ceramide-1-phosphate alleviates high-altitude pulmonary edema by stabilizing circadian ARNTL-mediated mitochondrial dynamics;Journal of Advanced Research;2023-07